1. Home
  2. Analysis
  3. Oxaliplatin
  4. Red-cell-distribution-width-increased

Oxaliplatin and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

Red cell distribution width increased is reported as a side effect among people who take Oxaliplatin (oxaliplatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Dexamethasone, and have Cholangiocarcinoma.

The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Oxaliplatin. It is created by eHealthMe based on reports of 71,972 people who have side effects when taking Oxaliplatin from the FDA, and is updated regularly.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 607 drugs and 653 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.

On Jul, 08, 2026

71,972 people reported to have side effects when taking Oxaliplatin.
Among them, 35 people (0.05%) have Red cell distribution width increased.

Could Oxaliplatin cause Red cell distribution width increased?

Among these 35 people:

How long have people been on Oxaliplatin when they have Red cell distribution width increased? *

  • < 1 month: 7.69 %
  • 1 - 6 months: 84.62 %
  • 6 - 12 months: 7.69 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Red cell distribution width increased when taking Oxaliplatin? *

  • female: 16.67 %
  • male: 83.33 %

What is the age of people who have Red cell distribution width increased when taking Oxaliplatin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 25.0 %
  • 40-49: 20.83 %
  • 50-59: 20.83 %
  • 60+: 33.33 %

What are other drugs people take besides Oxaliplatin? *

  1. Dexamethasone: 11 people, 31.43%
  2. Gemcitabine: 10 people, 28.57%
  3. Methylprednisolone: 10 people, 28.57%
  4. Cyclophosphamide: 10 people, 28.57%
  5. Bendamustine: 9 people, 25.71%
  6. Ifosfamide: 9 people, 25.71%
  7. Cytarabine: 9 people, 25.71%
  8. Cisplatin: 9 people, 25.71%
  9. Carboplatin: 9 people, 25.71%
  10. Vincristine Sulfate: 9 people, 25.71%

What are other side effects people have besides Red cell distribution width increased? *

  1. Haemoglobin Decreased: 30 people, 85.71%
  2. Red Blood Cell Count Decreased: 21 people, 60.00%
  3. Haematocrit Decreased: 19 people, 54.29%
  4. Blood Lactate Dehydrogenase Increased: 16 people, 45.71%
  5. Thrombocytopenia (decrease of platelets in blood): 15 people, 42.86%
  6. C-Reactive Protein Increased: 13 people, 37.14%
  7. Disease Progression: 13 people, 37.14%
  8. White Blood Cell Count Increased: 12 people, 34.29%
  9. Monocyte Count Increased: 12 people, 34.29%
  10. Drug Ineffective: 11 people, 31.43%

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.57%
  2. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 8.57%
  3. Breast Cancer Metastatic: 2 people, 5.71%
  4. Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 5.71%
  5. Hepatic Cancer Metastatic (liver cancer - metastatic): 2 people, 5.71%
  6. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 2.86%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.86%
  8. Cardiac Disorder: 1 person, 2.86%
  9. Colorectal Cancer Stage Iii (colon and rectal cancer spreads to lymph nodes): 1 person, 2.86%
  10. Constipation: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Oxaliplatin and have Red cell distribution width increased?

- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxaliplatin:

Red cell distribution width increased treatments and more:

How severe was Red cell distribution width increased and when was it recovered:

Expand to all the drugs that have ingredients of oxaliplatin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxaliplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Red cell distribution width increased:

Browse all the conditions that are associated with Red cell distribution width increased:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on oxaliplatin (the active ingredients of Oxaliplatin) and Oxaliplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.